IDMA urges US FDA to reduce Generic Drug User Fee on Indian ph...

Indian Drug Manufacturers' Association (IDMA) and global safety science company UL today entered into an alliance for providing tools and training to domestic companies to mitigate regulatory scrutiny and to meet the increased compliance levels. The alliance ...

KARACHI: Pakistan Pharmaceutical Manufacturers Association (PPMA) fears that the intrusion of Indian cheap substandard drugs after the grant of non-discriminatory market access (NDMA) status to

The All India Organization of Chemists & Druggists (AIOCD), an association that represents chemists and pharmaceutical drug retailers, has ventured into the manufacture and retail of medicines. AIOCD, which represents about 750,000 chemists and ...

Drug quality concerns, such as those that have banned U.S. sales of generic medicines from several Indian manufacturing plants, have spurred regulators to create a new unit to sharpen their oversight. The Food and Drug Administration is ...

Mumbai: The US Food and Drug Administration (USFDA) on Thursday banned Ranbaxy's India-based plants from manufacturing and distributing active pharmaceutical ingredients. The move has renewed fears among the Indian medical fraternity about ...

order by India's antitrust regulator asking the pharmaceutical trade lobby group to stop monopolistic practices that affect the supply of essential medicines, the stand-off between drug makers and the trade association continues to cripple the ...

The US health regulator has found significant violations of good manufacturing norms at the Indian drug company Jubilant Life Sciences' Washington facility for finished pharmaceuticals. The manufacturing facilities, Jubilant HollisterStier, LLC (JHS) located ...

/PRNewswire/ -- .com announces that a new market research report is available in its catalogue: Report Details Treating Parkinson's - how you find business trends, R&D, and revenue forecasts See the future of Parkinson's drugs. For those ...

Last week, the U.S. Trade Representative announced it is taking action against India at the World Trade Organization to challenge India's domestic content requirements that discriminate against U.S. exports by requiring solar power developers to use ...